Email Updates

You are here

New Resources on!


Tuesday, February 23, 2021
Antibody Related Research, General, Microbicides, Multipurpose Prevention Technologies, PrEP

Read on for a roundup of new resources on and!

It’s one year into the COVID-19 pandemic, and the pace of advocacy for many people has only accelerated. In this time, when vast quantities of information—good and bad—must be sorted and priorities set, AVAC has been generating resources to help you keep up-to-date and to inform your advocacy.

HIVR4P in 3D

Okay, maybe it’s not really three dimensions; it’s more! Catch up on many angles of R4P starting with AVAC’s coverage:

Recordings from the Advocates’ Corner went deep into the content and include insightful, lively exchanges:

Funding for HIV Prevention R&D

The 16th annual analysis of funding trends in HIV Prevention R&D is out with 2019 data, and it can all be found on a newly launched website: The annual report is a collaboration among AVAC, IAVI and UNAIDS, and the website includes 20 years of funding trends.

1 Million PrEP Initiations...almost

These two resources will help you understand the trends in PrEP uptake, and keep you up-to-date on PrEP initiations around the world, which is fast approaching 1 million but still well below global targets.

Ending TB

AVAC, Partners in Health, Friends of the Global Fight, Results, Treatment Action Group (TAG) and the Zero TB Initiative collaborated on a report and a new website that includes case studies from around the world. Find out what successful programs in Cambodia, Ethiopia, Pakistan, Russia, South Africa and the United States have in common and learn more about the critical components needed to achieve the eradication of TB.

Protecting Global Gains

Two new vignettes on Protecting Global Gains explore how communities are adapting to maintain critical healthcare as COVID-19 threatens hard-won gains in global health. This project is a collaboration including AVAC, Partners in Health, Friends of the Global Fight, Results, Treatment Action Group (TAG) and the Zero TB Initiative.